Home › Funds › Artia Global Partners LP › CYTK

Artia Global Partners LP position in CYTK

CYTOKINETICS INC · Health Care

Artia Global Partners LP reported holding 70,700 shares of CYTK (CYTOKINETICS INC) in its Q2 2026 13F filing — a position valued at US$6.0M, representing 1.11% of its reported portfolio and ranking #19 among its reported holdings. Artia Global Partners LP has disclosed CYTK holdings in 4 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)70.70K sh
Reported value held$6.02M
Portfolio Weight1.11%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's CYTK position evolved

Artia Global Partners LP first disclosed a stake in CYTK in Q4 2023 at 32,113 shares (US$2.7M). The position peaked in Q1 2024 at 89,525 shares, worth US$6.3M. Across 4 filings, Artia Global Partners LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 70,700 shares valued at US$6.0M — an increase of 54,400 shares quarter over quarter.. Notable position changes include a 179% increase in Q1 2024 (shares fell 23% over the following quarter), a 334% increase in Q2 2026 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 32.11K $2.68M New
Q1 2024 89.53K $6.28M Add
Q1 2026 16.30K $1.07M New
Q2 2026 70.70K $6.02M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 52 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has Artia Global Partners LP held CYTK?

Artia Global Partners LP has disclosed CYTK holdings in 4 of the last 11 reported quarters, going back to Q4 2023.

What is Artia Global Partners LP's current position in CYTK?

As of Q2 2026, Artia Global Partners LP holds 70.70K shares of CYTK (CYTOKINETICS INC), valued at $6.02M, representing 1.11% of its reported portfolio and ranking #19.

Has Artia Global Partners LP been buying or selling CYTK?

In the latest 13F filing (Q2 2026), Artia Global Partners LP increased its position in CYTK. The position peaked in Q1 2024 at 89.53K shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.